Publications

Filter results by

Filtered by:

Emily Ko

List of Publications

Title Date PC3I Authors Journal
Racial disparities in receipt of radiation and brachytherapy in cervical cancer patients and impact on survival outcomes: Do they exist in a SEER-Medicare population? (2124) September 1, 2023
PC3I Authors
Emily Gleason; Emily Ko
Gynecologic Oncology
Cost of care associated with utilization of telehealth in clinical trials. May 31, 2023
PC3I Authors
Emily Gleason; Emily Ko
Journal of Clinical Oncology
Telehealth utilization in gynecologic oncology clinical trials September 2, 2023
PC3I Authors
Emily Ko; Emily Gleason
Gynecologic Oncology
The frequency and persistence of lymphedema diagnosis and self-reported symptoms over 5 years in patients with endometrial carcinoma May 20, 2022
PC3I Authors
Emily Ko
Gynecologic Oncology Reports
Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion June 1, 2022
PC3I Authors
Emily Ko
International Journal of Gynecological Cancer
Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database June 6, 2022
PC3I Authors
Emily Ko
Gynecologic Oncology
An evaluation of the microbiota of the upper reproductive tract of women with and without epithelial ovarian cancer June 27, 2022
PC3I Authors
Emily Ko
Gynecologic Oncology Reports
Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation July 5, 2022
PC3I Authors
Emily Ko
International Journal of Gynecological Cancer
Safety of ovarian preservation for premenopausal patients with FIGO stage I grade 2 and 3 endometrioid endometrial adenocarcinoma July 26, 2022
PC3I Authors
Emily Ko
International Journal of Gynecological Cancer
Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and Outcomes August 4, 2022
PC3I Authors
Emily Ko
American Journal of Clinical Oncology
Disparities in biomarker testing in ovarian cancer: a real-world analysis August 25, 2022
PC3I Authors
Anna Jo Smith; Emily Ko
American Journal of Obstetrics and Gynecology
Predictive value of 5-Factor modified frailty index in Oncologic and benign hysterectomies September 2, 2022
PC3I Authors
Emily Ko
Gynecologic Oncology Reports
Prior authorization in gynecologic oncology: An analysis of clinical impact October 16, 2022
PC3I Authors
Anna Jo Smith; Lakeisha Mulugeta-Gordon; Justin Bekelman; Emily Ko
Gynecologic Oncology
Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovarian carcinoma December 12, 2022
PC3I Authors
Emily Ko
Gynecologic Oncology
Insurance and racial disparities in prior authorization in gynecologic oncology March 21, 2023
PC3I Authors
Anna Jo Smith; Lakeisha Mulugeta-Gordon; Justin Bekelman; Emily Ko
Gynecologic Oncology Reports
Disparities in clinical trial participation in ovarian cancer: A real-world analysis June 10, 2023
PC3I Authors
Anna Jo Smith; Emily Ko
Gynecologic Oncology
Early-career and fellow gynecologic oncologists perceive underpreparedness for the business of medicine: A Society of gynecologic oncology survey study September 21, 2024
PC3I Authors
Emily Ko
Gynecologic Oncology Reports
Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients July 3, 2023
PC3I Authors
Anna Jo Smith; Emily Ko
Gynecologic Oncology Reports
Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma August 23, 2023
PC3I Authors
Emily Ko
Gynecologic Oncology
Current diagnostic guidelines and perpetuation of inequities in ovarian cancer: A National Cancer Database study. May 29, 2024
PC3I Authors
Anna Jo Smith; Emily Gleason; Anne Marie McCarthy
Journal of Clinical Oncology